Paper · 40211787
The molecular landscape of AL amyloidosis.
Zvida-Bloch T and 4 others. Br J Haematol, 2025. Cited by 9 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The molecular landscape of AL amyloidosis. Papers, record 40211787. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40211787
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunoglobulin Light-chain Amyloidosis | Major topic |
| Humans | |
| Proteomics | |
| Mutation | |
| Transcriptome |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50 CA186781 | NCI NIH HHS | United States | P50CA186781 | PubMed and NIH | NIH RePORTER |
| 0005792 | The Israeli Ministry of Innovation, Science and Technology | PubMed | PubMed |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References109
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39,350,582 | Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. | Amyloid | 2024 | https://conductscience.org/library/papers/39350582 | PubMed |
| 2 | 22,100,494 | Clonal plasma cell pathophysiology and clinical features of disease are linked to clonal plasma cell expression of cyclin D1 in systemic light-chain amyloidosis. | Clin Lymphoma Myeloma Leuk | 2012 | https://conductscience.org/library/papers/22100494 | PubMed |
| 3 | 33,431,806 | Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis. | Blood Cancer J | 2021 | https://conductscience.org/library/papers/33431806 | PubMed |
| 4 | 33,425,465 | AL Amyloidosis: Unfolding a Complex Disease. | J Adv Pract Oncol | 2019 | https://conductscience.org/library/papers/33425465 | PubMed |
| 5 | 30,327,369 | Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma. | Blood Adv | 2018 | https://conductscience.org/library/papers/30327369 | PubMed |
| 6 | 32,943,087 | BCMA-targeted immunotherapy for multiple myeloma. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/32943087 | PubMed |
| 7 | 28,025,584 | Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma. | Leukemia | 2017 | https://conductscience.org/library/papers/28025584 | PubMed |
| 8 | 9,447,971 | Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. | Mol Cell Biol | 1998 | https://conductscience.org/library/papers/9447971 | PubMed |
| 9 | 30,104,177 | Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p. | Clin Lymphoma Myeloma Leuk | 2018 | https://conductscience.org/library/papers/30104177 | PubMed |
| 10 | 27,288,311 | Does AL amyloidosis have a unique genomic profile? Gene expression profiling meta-analysis and literature overview. | Gene | 2016 | https://conductscience.org/library/papers/27288311 | PubMed |
1 to 10 of 109
See all 109 referencesCited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,278,643 | Multiple Myeloma Concomitant with AL Amyloidosis: Histopathological Aspects of the Common Plasma Cell Spectrum. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278643 | PubMed |
| 42,258,481 | Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates. | CA Cancer J Clin | 2026 | https://conductscience.org/library/papers/42258481 | PubMed |
| 42,252,535 | Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis. | Am J Hematol | 2026 | https://conductscience.org/library/papers/42252535 | PubMed |
| 41,898,891 | Exploring the MicroRNA Landscape in Cardiac Amyloidosis: Molecular Insights and Clinical Applications. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/41898891 | PubMed |
| 41,309,103 | [Diagnosis of Amyloidosis in Hand and Plastic Surgery Patients: Optimal Tissue Selection and Examination Methods for Early Detection]. | Handchir Mikrochir Plast Chir | 2026 | https://conductscience.org/library/papers/41309103 | PubMed |
| 40,211,787 | The molecular landscape of AL amyloidosis. | Br J Haematol | 2025 | https://conductscience.org/library/papers/40211787 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40211787
GET https://conductscience.org/api/papers/v1/40211787/references?page=2